Genetics Generation Advancement Corp. (4160.TWO)

TWD 54.2

(3.83%)

Eps Summary of Genetics Generation Advancement Corp.

  • Genetics Generation Advancement Corp.'s latest annual eps in 2023 was 1.07 TWD , up 10.89% from previous year.
  • Genetics Generation Advancement Corp.'s latest quarterly eps in 2024 Q2 was 0.72 TWD , up 28.57% from previous quarter.
  • Genetics Generation Advancement Corp. reported an annual eps of 1.01 TWD in 2022, up 225.81% from previous year.
  • Genetics Generation Advancement Corp. reported an annual eps of 0.31 TWD in 2021, up 150.0% from previous year.
  • Genetics Generation Advancement Corp. reported a quarterly eps of 0.56 TWD for 2024 Q1, up 107.41% from previous quarter.
  • Genetics Generation Advancement Corp. reported a quarterly eps of 0.27 TWD for 2023 Q4, up 42.11% from previous quarter.

Annual Eps Chart of Genetics Generation Advancement Corp. (2023 - 2019)

Historical Annual Eps of Genetics Generation Advancement Corp. (2023 - 2019)

Year Eps Eps Growth
2023 1.07 TWD 10.89%
2022 1.01 TWD 225.81%
2021 0.31 TWD 150.0%
2020 -0.62 TWD -189.86%
2019 0.69 TWD 0.0%

Peer Eps Comparison of Genetics Generation Advancement Corp.

Name Eps Eps Difference
BIONET Corp. 1.55 TWD 30.968%
DIVA Laboratories, Ltd. 1.25 TWD 14.4%
Welgene Biotech Co.,Ltd. -0.11 TWD 1072.727%
Puriblood Medical Co., Ltd. -3.63 TWD 129.477%
TFBS Bioscience Inc. 0.17 TWD -529.412%